These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22994957)

  • 1. Nanostructuring molecular materials as particles and vesicles for drug delivery, using compressed and supercritical fluids.
    Elizondo E; Veciana J; Ventosa N
    Nanomedicine (Lond); 2012 Sep; 7(9):1391-408. PubMed ID: 22994957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
    Hunter AC; Elsom J; Wibroe PP; Moghimi SM
    Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals.
    Pasquali I; Bettini R; Giordano F
    Adv Drug Deliv Rev; 2008 Feb; 60(3):399-410. PubMed ID: 17964684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery systems based on nucleic acid nanostructures.
    de Vries JW; Zhang F; Herrmann A
    J Control Release; 2013 Dec; 172(2):467-83. PubMed ID: 23742878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A regulated delivery system for inner ear drug application.
    Lajud SA; Han Z; Chi FL; Gu R; Nagda DA; Bezpalko O; Sanyal S; Bur A; Han Z; O'Malley BW; Li D
    J Control Release; 2013 Mar; 166(3):268-76. PubMed ID: 23313113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections.
    Gamazo C; Prior S; Concepción Lecároz M; Vitas AI; Campanero MA; Pérez G; Gonzalez D; Blanco-Prieto MJ
    Expert Opin Drug Deliv; 2007 Nov; 4(6):677-88. PubMed ID: 17970669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silicon: a platform for the delivery of therapeutics.
    Prestidge CA; Barnes TJ; Lau CH; Barnett C; Loni A; Canham L
    Expert Opin Drug Deliv; 2007 Mar; 4(2):101-10. PubMed ID: 17335408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of plastic nano-hydroxyapatite/poly (3-hydroxybutyrate-hydroxyvalerate)-polymethyl lene glycol gentamicin drug delivery system].
    Tang S; Jin A; Wang Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Jul; 20(7):758-61. PubMed ID: 16892815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic therapeutic delivery using navigable agents.
    Martel S
    Ther Deliv; 2014 Feb; 5(2):189-204. PubMed ID: 24483196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hydrogel template method for fabrication of homogeneous nano/microparticles.
    Acharya G; Shin CS; McDermott M; Mishra H; Park H; Kwon IC; Park K
    J Control Release; 2010 Feb; 141(3):314-9. PubMed ID: 19822178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid lipid nanoparticles for parenteral drug delivery.
    Wissing SA; Kayser O; Müller RH
    Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances.
    Buse J; El-Aneed A
    Nanomedicine (Lond); 2010 Oct; 5(8):1237-60. PubMed ID: 21039200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and Stability Aspects of Nanosized Solid Drug Delivery Systems.
    Szabo P; Zelko R
    Curr Pharm Des; 2015; 21(22):3148-57. PubMed ID: 26027571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial nanomedicine.
    Yacoby I; Benhar I
    Nanomedicine (Lond); 2008 Jun; 3(3):329-41. PubMed ID: 18510428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nanotechnology in targeted drug delivery and imaging: a concise review.
    Koo OM; Rubinstein I; Onyuksel H
    Nanomedicine; 2005 Sep; 1(3):193-212. PubMed ID: 17292079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.